CVS Health is trading at $86.51 (-5.36%) in pre-market amid plans to separate its retail pharmacy business by 2028.
- Third-quarter revenue reached $108.4 billion, and adjusted EPS was $2.09.
- Management raised full-year adjusted EPS guidance to at least $8.20.
- The separation would divide retail pharmacy from healthcare and pharmacy-benefits operations. Reports said shares fell in pre-market after the announcement, suggesting the plans may weigh on sentiment despite the earnings beat.